Progress in TLR4/NF-κB Pathway Regulation by Traditional Chinese Medicine for the Treatment of Polycystic Ovary Syndrome

Authors

  • Yue Li Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi, China; Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, Shaanxi, China
  • Hongli Zhu Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, Shaanxi, China

DOI:

https://doi.org/10.53469/jcmp.2024.06(10).05

Keywords:

NA

Abstract

Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disease in women, affecting women's fertility and cardiovascular system. Due to the complexity of its pathogenesis, there are many adverse reactions commonly used in clinical treatment, and the therapeutic effect is short-lived and temporary. TLR4/NF-κB pathway is a classical signaling pathway related to inflammation, and the effective components of TCM compounds and TCM monomers have been proven to reduce the levels of various inflammatory factors in patients by regulating the TLR4/NF-κB pathway, so as to achieve the effect of PCOS. The potential value of TCM in prevention and treatment of PCOS based on TLR4/NF-κB pathway was revealed. This article aims to summarize the recent studies on the improvement of PCOS symptoms by regulating the expression of TLR4/NF-κB pathway by Chinese medicine, so as to further study the mechanism of PCOS prevention and treatment by this pathway under the regulation of Chinese medicine, so as to open up new ideas for the development of new drugs targeting this pathway and clinical research.

References

Qian Yi, Ma Xiang. Interpretation of diagnosis criteria for polycystic ovary syndrome[J]. Chinese Journal of Practical Gynecology and Obstetrics, 2019, 35(03): 264-267.

Harsha Varma, Sree., Tirupati, Sunanda., Pradeep, T V S., Sarathi, Vijaya., Kumar, Dileep.. Insulin resistance and hyperandrogenemia independently predict nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Diabetes & metabolic syndrome, 2019, 13(2):1065-1069.

Gao Huihui, Qian Beiran, Niyan, et. Research Progress in the Pathogenesis of Polycystic Ovary Syndrome[J]. ournal of Sichuan University (Medical Sciences), 2024, 55(04):1049-1054.

Harris Holly R, Cushing-Haugen Kara L, Webb Penelope M, et al. Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study. [J]. International journal of epidemiology, 2019, 48(3):822-830.

Jessica Cornice, Daniela Verzella, Paola Arboretto, et al. NF-κB: Governing Macrophages in Cancer[J]. Genes, 2024, 15(2):197.

Zhang Miaomiao, Sun Xin. Research progress of hyperandrogenism in polycystic ovary syndrome[J]. Journal of Reproductive Medicine, 2024, 33(08): 1114-1119.

Yu Wencai, Wang Chunxia, Li Pengchao, et al. Methods of Diagnosis and Treatment of Polycystic Ovary Syndrome with Traditional Chinese Medicine[J/OL]. Liaoning Journal of Traditional Chinese Medicine, 1-6[2024-09-05].

Spritzer Poli Mara, Lecke Sheila B, Satler Fabíola, et al. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. [J]. Reproduction (Cambridge, England), 2015, 149(5): R219-27.

Muzio M, Polentarutti N, Bosisio D, et al. Toll-like receptor family and signalling pathway. [J]. Biochemical Society transactions, 2000, 28(5):563-566.

Kim Hyo Jin, Kim Hyemin, Lee Jeong Hyung, et al. Toll-like receptor 4 (TLR4): new insight immune and aging[J]. Immunity & Ageing, 2023, 20(1):67-67.

Wang Yang, Liu Yanxia, Tong Qing, et. Guizhu Yikun Formula Combined with Fecal Microbiota Transplantation Treats Polycystic Ovary Syndrome in Rats via TLR-4/NF-κB Signaling Pathway[J]. World Journal of Integrated Traditional and Western Medicine, 2023, 18(05):855-861.

Yang Ping. Research Progress on the Effect of TCM on the Signal Pathway of Knee Osteoarthritis[J]. Rheumatism and Arthritis, 2022, 11(12):71-75.

Hua Binghong. The study of Toll-like receptor 4 and impaired glucosemetabolism in rat adjuvant induced arthritis[D]. Nanchang University, 2014.

Lu Xinyu, Chen Qianhui, Liu Hongyan, et al. Interplay Between Non-Canonical NF-κB Signaling and Hepatitis B Virus Infection[J]. Frontiers in Immunology, 2021, 12:730684-730684.

Yao Zhilin, Huang Yinghong, Xv Xiaojuan. Effect of Bushen Huayu Recipe Combined with Metformin on TLR4/NF-κB Inflammatory Signal Pathway, Oxidative Stress and Insulin Resistance in Female Rats with Polycystic Ovary Syndrome[J]. Journal of Sichuan of Traditional Chinese Medicine, 2019, 37(11):63-68.

Zhang Yachen, Sun Jianguo. Research Progress of Berberine in Prophylactic Treatment of Diabetic Nephropathy[J]. Progress in Pharmaceutical Sciences, 2023, 47(03):217-226.

Xv Haiyan, Du Qing, Chen Juan, et. Effect of cangfudaotan decoction on TLR4/NF-κB p65 signaling pathway in obese PCOS-IR rats[J]. Chinese Pharmacological Bulletin, 2023, 39(04):787-793.

Pan Guiqun, Sun Dongsheng. Effects of rosuvastatin on NF-κB expression in obese rats' myocardium[J]. China Modern Doctor, 2015, 53(01):4-6+9.

Cui Meiting, Hong Yanli, Huang Jingyu, et. Efficiency of Chinese medicine Bushen Huatan formula for treatment of polycystic ovary syndrome in mice via regulating gut microbiota and PPARγ pathway[J]. Journal of Zhejiang University (Medical Sciences), 2023, 52(01):33-45.

Xie Pengpeng, Zeng Lei, Yu Jingwei, et. Effect of Modified Cangfu Daotantang on Metabolism and Pregnancy in Patients with Polycystic Ovary Syndrome[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2021, 27(14):87-92.

Wang Longhui, Guan Yu, Ni Xiaorong. HMGB1 Mediates NF-k B Pathway in Promoting the Apoptosis of Insulin Resistant Cell Model of Polycystic Ovary Syndrome[J]. Journal of Hunan University of Chinese Medicine, 2018, 38(04):379-383.

Wu Xiaozhen, He Jialun, Zeng Lei, et. Investigation of the Therapeutic Effect of Cangfu Daotan Decoction on Polycystic Ovary Syndrome Rats of Phlegm-damp Type Based on TLR-4/NF-κB Signaling Pathway[J]. Traditional Chinese Drug Research and Clinical Pharmacology, 2022, 33(03):307-312.

Gao Jianlian, Li Hanwei, Deng Zhijian, et. Effect and mechanism of methanolic extract of Eupatorium to model rats with chronic muscle injury[J]. Chinese Traditional Patent Medicine, 2018, 40(03):537-543.

Chang Zhuangpeng, Shao Yunyun, Liu Junjin, et. Effect of Modified Shaoyao Gancao Decoction on NF-κB Signaling Pathway in Ovarian Tissue of Polycystic Ovarian Syndrome Rats[J]. Chinese Archives of Traditional Chinese Medicine, 2019, 37(09):2295-2300+2322.

Liu Bo, Zhang Chengqi, Dong Qing, et. Mechanism study on treatment of Tanshi type polycystic ovarian syndrome with Huayu Jiangzhuo formula[J]. Shaanxi Journal of Traditional Chinese Medicine, 2024, 45(07):888-892.

Lyle Sarah M., Ahmed Samah, Elliott Jason E., et al. Transcriptome-wide association analyses identify an association between ARL14EP and polycystic ovary syndrome[J]. Journal of Human Genetics, 2023, 68(5):347-353.

Cong Peiwei, Zhang Lina, Wang Dan, et al. Effects of Erchen Decoction on Endocrine and Glucose and Lipid Metabolism of PCOS Rats with Phlegm-Dampness Syndrome[J]. Chinese Archives of Traditional Chinese Medicine, 2021, 39(08):58-61+264.

Cong Peiwei, Zhang Lina, ZHao Danyu, et. Study of Erchen Decoction on Improving The Function of Qlucose Transport in The Uterus of PCOS Rats with Phlegm Dampness Syndrome by Enhancing Autophagy [J]. Journal of Basic Chinese Medicine, 2021, 27(08): 1270-1274.

Shi Shumei, Jiang Peipei, Wang Xiaoyan, et al. Regulation of Erchen Decoction on NF-κB and NLRP3 mediated inflammatoryresponse in ovaries of rats with polycystic ovary syndrome[J]. Journal of Hunan University of Chinese Medicine, 2023, 43(06):968-973.

Leng Chai, Li Dawei, Li Qiang. Therapeutic Effect And Mechanism of Different Intensity Exercise with Puerarin in Rats Models of Nonalcoholic Fatty Liver Disease[J]. Chinese Archives of Traditional Chinese Medicine, 2018, 36(02):452-455.

Zhu Junyao, Shi Zhongliang, Guo Liheng. A Review on the Mechanism of Tetramethylpyrazine in the Treatment of Sepsis [J]. Journal of Emergency in Traditional Chinese Medicine, 2019, 28(10):1864-1867.

Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats[J]. Frontiers in Pharmacology, 2017, 8:42.

Tu Jun, Zhu Shunlan, Zhou Xiaomei. Differentiated hypoglycemic effects of baicalin, berberine and puerarin on insulin-resistance HepG2 cells[J]. China Journal of Chinese Materia Medica, 2018, 43(20):4097-4103.

Liu Li, Zhuang Yao, Ding Shumin, et. Research progress on the use of traditional Chinese medicine and its effective components to prevent neuropathic pain[J]. Jiangsu Medical Journal, 2024, 50(07):733-737.

Zhou Zhi, Tu Zhihua, Li Yejuan, et. Effects of ligustrazine on ovarian function and PPAR-γ/NF-κB pathway in rats with polycystic ovary syndrome[J]. Chinese Traditional Patent Medicine, 2023, 45(01): 251-254.

WANG Yujing, DU Zhixiang, ZHANG Xia, et al. Effect of Hippophae rhamnoides Flavone on Improving Polycystic OvarianSyndrome in Rats by Regulating TLR4/NF-κB Signaling Pathway[J]. Science and Technology of Food Industry, 2024, 45(16):340−347.

Liu Shengwen, Liu Jianying. Advances in the pharmacological effects of quercetin[J]. Chinese Journal of Lung Diseases (Electronic Edition), 2020, 13(01): 104-106.

Zhenzhi Wang, Dongxia Zhai, Danying Zhang, et al. Quercetin Decreases Insulin Resistance in a Polycystic Ovary Syndrome Rat Model by Improving Inflammatory Microenvironment [J]. Reproductive Sciences, 2017, 24(5):682-690.

Gong Huijie, Tang Jianrong, Yao Lanjie, et. Inhibitory effect of artesunate on malignant biological behavior of human colorectal cancer CCL229 cells through miR-21/PTEN pathway[J]. Chinese Traditional and Herbal Drugs, 2021, 52(08):2331-2342.

Yang Yijiao, Yang Ling, Qi Cao, et al. Cryptotanshinone alleviates polycystic ovary syndrome in rats by regulating the HMGB1/TLR4/NF‑κB signaling pathway. [J]. Molecular medicine reports, 2020, 22(5):3851-3861.

Ma Xiaohong, Li Xiaorong, Ma LiLi, et al. Soy isoflavones alleviate polycystic ovary syndrome in rats by regulating NF- κB signaling pathway. [J]. Bioengineered, 2021, 12(1):7215-7223.

WANG Yujing, DU Zhixiang, ZHANG Xia, et al. Effect of Hippophae rhamnoides Flavone on Improving Polycystic OvarianSyndrome in Rats by Regulating TLR4/NF-κB Signaling Pathway[J]. Science and Technology of Food Industry, 2024, 45(16):340−347.

Liu Shengwen, Liu Jianying. Advances in the pharmacological effects of quercetin[J]. Chinese Journal of Lung Diseases (Electronic Edition), 2020, 13(01): 104-106.

Brenjian Samaneh, Moini Ashraf, Yamini Nazila, et al. Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers. [J]. American journal of reproductive immunology (New York, N.Y.: 1989), 2020, 83(1):e13186.

Chen Jiqing, Szodoray Peter, Zeher Margit, et al. Toll-Like Receptor Pathways in Autoimmune Diseases. [J]. Clinical reviews in allergy & immunology, 2016, 50(1):1-17.

Shen Lingyu, Hu Hui. Discussion on the theory of Tongtiao belt pulse treatment for abdominal obese polycystic ovary syndrome[J]. Global Traditional Chinese Medicine, 2017, 10(10):1241-1243.

Shen Lingyu, Chang Xiongfei, Pan Liang, et. Effect of Electro-Acupuncture on NFκB Signaling Pathway in Hypothalamus of PCOS-IR Rats[J]. Journal of Clinical Acupuncture and Moxibustion, 2022, 38(03):72-76.

Downloads

Published

2024-10-29

How to Cite

Li, Y., & Zhu, H. (2024). Progress in TLR4/NF-κB Pathway Regulation by Traditional Chinese Medicine for the Treatment of Polycystic Ovary Syndrome. Journal of Contemporary Medical Practice, 6(10), 22–27. https://doi.org/10.53469/jcmp.2024.06(10).05